Fact-sheet: Inflammatory pseudotumor of the lung


Updated on 04/23/2018 at 9:21 AM

Note : 0/10

View all RADEOS cases associated with this fact-sheet

Definition

- Rare benign lung tumor (0.7 to 1% of bronchopulmonary tumors)

- Predominantly pulmonary parenchymal, rarely endobronchial in children

- Initially described in 1921 by Symmers as an unusual form of malignant lung tumor

- Presenting as a solitary nodule, mimicking a malignant tumor.

- Unknown etiology (immunologic response to an infectious or non-infectious agent according to some authors)

- More than half of cases occur before age 40, and 15% between 1 and 10 years of age

Clinical features

- Asymptomatic lesion in 50% of cases

- Otherwise:

  • cough
  • hemoptysis
  • dyspnea
  • chest pain
  • cyanosis
  • digital clubbing
  • In 15 to 30% of cases, systemic signs (fever, growth retardation, weight loss)

Radiography

- round, well-circumscribed solitary nodule

- intraparenchymal

- mean size of 4 cm

CT

- mass with regular margins

- occasionally cavitated

- calcifications in 25% of cases

- assessment for local invasion and extrapulmonary involvement

Nuclear medicine

- PET/CT: hypermetabolism related to inflammatory changes

Management

- Surgical treatment (segmentectomy, lobectomy, or pneumonectomy)

- Oncologic resection justified by the angioinvasion sometimes described, the possible microscopic invasion of adjacent tissue, and the potentially malignant nature of these tumors.

- Some cases of spontaneous regression after biopsy have been reported in the literature

Classification

- Coffin WHO histologic classification

  • Type 1: "myxoid vascular" (myofibroblasts within a granular tissue)
  • Type 2: "compact spindle" (cellular proliferation with variable myxoid and collagenous regions)
  • Type 3: "hypocellular fibrous" (scar-like appearance with rare inflammatory cells)

- Matsubara histologic classification:

  • Type I "organizing pneumonia" (44%) featuring intra-alveolar inflammation progressing to peripheral alveolar fibrosis and central interstitial fibrosis.
  • Type II "fibrohistiocytic" (44%) corresponds to an intense proliferation of spindle cells and histiocytes.
  • Type III "lymphoplasmacytic" (12%) predominance of lymphocytes and plasma cells with little fibrosis.